International Stem Cell CORP (ISCO) financial statements (2022 and earlier)

Company profile

Business Address 5950 PRIESTLY DRIVE
CARLSBAD, CA 92008
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1716894841,075304110532
Cash and cash equivalents1716894841,075304110532
Receivables8444031,515651465574539
Inventory, net of allowances, customer advances and progress billings1,1849171,2461,5011,3071,3901,348
Inventory1,1849171,2461,5011,3071,3901,348
Deferred tax assets   136
Other undisclosed current assets135174207543779418436
Total current assets:2,3342,1833,4523,7702,8552,4922,991
Noncurrent Assets
Inventory, Noncurrent372371358805692615489
Operating lease, right-of-use asset868874717
Property, plant and equipment384534668469321396375
Intangible assets, net (including goodwill)9491,2621,3352,6742,9223,4843,223
Intangible assets, net (excluding goodwill)9491,2621,3352,6742,9223,4843,223
Other undisclosed noncurrent assets39639078745860
Total noncurrent assets:2,6123,1043,1684,0264,0094,5534,147
TOTAL ASSETS:4,9465,2876,6207,7966,8647,0457,138
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9127461,2961,0371,4371,3061,926
Accounts payable5083606544588308411,092
Accrued liabilities404386642579607465834
Debt  367    
Due to related parties2,943  2,045  3,129
Other undisclosed current liabilities4297372501,9953,3632,295489
Total current liabilities:4,2841,4831,9135,0774,8003,6015,544
Noncurrent Liabilities
Long-term debt and lease obligation950845718    
Operating lease, liability950845718
Liabilities, other than long-term debt 2,4752,370182   
Deferred rent credit   182
Due to related parties 2,4752,370    
Other undisclosed noncurrent liabilities(950)517207    
Total noncurrent liabilities:9503,8373,295182   
Total liabilities:5,2345,3205,2085,2594,8003,6015,544
Stockholders' equity
Stockholders' equity attributable to parent, including:(4,588)(4,333)(2,888)2,5372,0643,4441,594
Common stock8887643
Additional paid in capital105,413104,769103,490109,188106,585101,89898,970
Accumulated deficit(110,014)(109,115)(106,391)(106,663)(104,532)(98,463)(97,384)
Other undisclosed stockholders' equity attributable to parent5555555
Other undisclosed stockholders' equity4,3004,3004,300    
Total stockholders' equity:(288)(33)1,4122,5372,0643,4441,594
TOTAL LIABILITIES AND EQUITY:4,9465,2876,6207,7966,8647,0457,138

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues7,1767,1289,47211,0897,4567,1657,551
Revenue, net7,4567,1657,551
Cost of revenue(2,935)(2,781)(3,933)(4,069)(2,122)(1,944)(2,056)
Financial services costs (928) 
Gross profit:4,2414,3475,5397,0205,3345,2215,495
Operating expenses(6,162)(7,165)(11,267)(10,494)(10,276)(10,072)(10,059)
Operating loss:(1,921)(2,818)(5,728)(3,474)(4,942)(4,851)(4,564)
Nonoperating income (expense)1,022941,4631,343(1,127)3,7721,929
Interest and debt expense1,009(113)(77)(48)(59)(6)(11)
Income (loss) from continuing operations before equity method investments, income taxes:110(2,837)(4,342)(2,179)(6,128)(1,085)(2,646)
Other undisclosed income from continuing operations before income taxes   4859611
Income (loss) before gain (loss) on sale of properties:110(2,837)(4,342)(2,131)(6,069)(1,079)(2,635)
Other undisclosed net income (loss)(1,009)11377    
Net loss available to common stockholders, diluted:(899)(2,724)(4,265)(2,131)(6,069)(1,079)(2,635)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(899)(2,724)(4,265)(2,131)(6,069)(1,079)(2,635)
Comprehensive loss, net of tax, attributable to parent:(899)(2,724)(4,265)(2,131)(6,069)(1,079)(2,635)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: